Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients

Abstract

TBRII gene and protein expression defect in MSC derived from SSc patients may have pathological significance. These findings should be taken into account when considering the use of MSC-based therapies in an autologous setting.